Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 48:467-475, November-December
doi: 10.1176/appi.psy.48.6.467
© 2007 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Wryobeck, J. M.
* Articles by Rubenfire, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Wryobeck, J. M.
* Articles by Rubenfire, M.
Related Collections
* Syndromes Secondary to General Medical Disorders

Review

Psychosocial Aspects of Pulmonary Hypertension: A Review

John M. Wryobeck, Ph.D., Giuseppina Lippo, M.D., Valerie McLaughlin, M.D., Michelle Riba, M.D., and Melvyn Rubenfire, M.D.

Received November 8, 2006; revised February 26, 2007; accepted March 16, 2007. From the Univ. of Toledo Dept. of Psychiatry; the Univ. of Michigan Dept. of Psychiatry; and the Univ. of Michigan, Division of Cardiovascular Medicine, Dept. of Internal Medicine. Send correspondence and reprint requests to John M. Wryobeck, Ph.D., Univ. of Toledo Health Science Campus; Dept. of Psychiatry; Mail Stop 1193, 3000 Arlington Ave.; Toledo, OH 43614. e-mail: John.Wryobeck{at}utoledo.edu
© 2007 The Academy of Psychosomatic Medicine

Pulmonary arterial hypertension (PAH) is characterized by progressive and sustained elevation of pulmonary-artery pressure, which ultimately leads to right-ventricular failure and death. The diagnosis carries with it an uncertain and historically very bleak prognosis. Although new oral and chronic parenteral (intravenous and subcutaneous) treatments have had a significant positive medical impact on the physical functioning of individuals with PAH, patients often struggle with new short- and long-term psychosocial challenges. The purpose of the current article is to 1) provide a brief review of PAH and its treatment; 2) summarize the limited literature examining the psychosocial adjustment of those with a PAH diagnosis; and 3) provide pertinent information extrapolated from the larger literature on chronic illness that might inform us on the psychosocial challenges faced by the patient diagnosed with PAH.







Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org